期刊文献+

IABP应用时机对高危PCI患者血流动力学及近期预后的影响 被引量:1

Influence of timing of IABP implantation on hemodynamics and short-term prognosis in patients with high-risk PCI
下载PDF
导出
摘要 目的 探讨主动脉内球囊反搏(intra-aortic balloon pump, IABP)应用时机对高危经皮冠状动脉介入(percutaneous coronary intervention, PCI)患者血流动力学及近期预后的影响。方法 回顾性分析2018年3月至2022年5月在廊坊市第四人民医院行IABP辅助的96例高危PCI患者的临床资料。根据IABP应用时机分为术前组(PCI前置入,n=56)和术后组(PCI后置入,n=40)。收集两组患者年龄、性别、合并疾病、冠心病类型、冠状动脉病变部位、左心室射血分数(left ventricular ejection fraction, LVEF)及心源性休克(cardiogenic shock, CS)、急性心肌梗死(acute myocardial infarction, AMI)合并机械并发症、室性心律失常(ventricular arrhythmia, VA)等术前临床资料。比较两组患者手术前后平均动脉压(mean arterial pressure, MAP)、心率(heart rate, HR)及尿量。记录两组患者支架置入数、无复流现象(TIMI血流分级≤2级)率、IABP运转时间、IABP并发症、再次PCI率、院内病死率、术后30 d病死率等。分析患者术后30 d死亡的危险因素。结果 (1)术前组糖尿病、高血脂比例、左前降支和左主干病变、ST段抬高型心肌梗死(ST segment levation myocardial infarction, STEMI)、CS比例高于术后组(P<0.05),难治性心绞痛比例低于术后组(P<0.05)。(2)两组术前MAP、HR、尿量比较差异无统计学意义(P>0.05),术后1 d MAP、HR、尿量均有明显改善,但术前组改善程度大于术后组(P<0.05)。(3)术前组IABP运转时间、再次PCI率、院内及术后30 d病死率低于术后组(P<0.05)。(4)Logistic多因素回归分析显示PCI后应用IABP是近期预后的独立危险因素(P=0.001)。结论 对于高危PCI患者,接受术前IABP置入相比术后IABP置入有更好的近期预后。 Objective To explore the influences of timing of intra-aortic balloon pump(IABP) implantation on hemodynamics and short-term prognosis in patients with high-risk percutaneous coronary intervention(HR-PCI). Methods The clinical data of 96 high-risk PCI patients received IABP in Fourth People’s Hospital of Langfang City from March 2018 to May 2022 were retrospectively analyzed. According to the timing of IABP implantation, all patients were divided into a preoperative group(IABP implantation before PCI, n=56) and a postoperative group(IABP implantation after PCI, n=40). Preoperative clinical data such as age, sex, combined disease, type of coronary heart disease, position of coronary artery disease, left ventricular ejection fraction(LVEF), and cardiogenic shock(CS), acute myocardial infarction(AMI) combined with mechanical complications, and ventricular arrhythmia(VA) were collected in the 2 groups.The mean arterial pressure(MAP), heart rate(HR), and urine volume before and after the operation were compared between the 2 groups. The stenting number, no blood flow rate(TIMI blood flow classification≤grade 2), IABP running time, IABP complications, recurrent PCI, nosocomial mortality, and 30 d postoperative mortality were recorded in the 2 groups. Risk factors of death≤30 d after operation were analyzed. Results(1)The proportion of diabetes, hyperlipidemia, left anterior descending branch and left main disease, STEMI, and CS in the preoperative group was higher than that in the postoperative group(P<0.05), and the proportion of refractory angina pectoris was lower than that in the postoperative group(P<0.05).(2)There were no statistically significant differences in MAP, HR, and urine volume before the operation between the 2 groups(P>0.05), while MAP, HR, and urine volume were significantly improved at the 1 d after the operation, but the improvement degree of the preoperative group was higher than that of the postoperative group(P<0.05).(3)IABP running time, rate of re-PCI, hospital mortality and 30 d postoperative mortality in the preoperative group were lower than those in the postoperative group(P<0.05).(4)Multivariate logistic regression analysis showed that IABP after PCI was an independent risk factor for short-term prognosis(P=0.001). Conclusion Compared with IABP implantation after PCI, IABP implantation before PCI can effectively improve the short-term prognosis of HR-PCI patients.
作者 梁军军 李婷婷 LIANG Junjun;LI Tingting(Intensive Care Unit,The Fourth People's Hospital of Langfang,Langfang 065700,China)
出处 《邵阳学院学报(自然科学版)》 2022年第5期52-58,共7页 Journal of Shaoyang University:Natural Science Edition
基金 河北省卫健委科研基金(20191416)。
关键词 主动脉内球囊反搏 经皮冠状动脉介入 应用时机 高危患者 血流动力学 预后 intra-aortic balloon pump percutaneous coronary intervention timing of implantation high-risk patient hemodynamics prognosis
  • 相关文献

参考文献7

二级参考文献122

  • 1托伐普坦临床研究协作组,张健,朱文玲.常规治疗基础上联用托伐普坦片治疗心原性水肿的有效性和安全性的多中心随机、双盲、安慰剂对照研究[J].中华心力衰竭和心肌病杂志(中英文),2017,1(1):15-21. 被引量:26
  • 2中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会,杨杰孚,张健,韩雅玲.中国心力衰竭诊断和治疗指南2018[J].中华心力衰竭和心肌病杂志(中英文),2018,2(4):196-225. 被引量:834
  • 3韩雅玲.中国经皮冠状动脉介入治疗指南2012(简本)[J].中国医学前沿杂志(电子版),2012,4(12):50-59. 被引量:133
  • 4钱菊英,吴鸿谊,张峰,葛雷,樊冰,王齐兵,刘学波,葛均波.高龄急性冠状动脉综合征患者经皮冠状动脉介入治疗的临床观察[J].中华老年心脑血管病杂志,2007,9(6):379-381. 被引量:11
  • 5Hal V. Barron,Nathan R. Every,Lori S. Parsons,Brad Angeja,Robert J. Goldberg,Joel M. Gore,Tony M. Chou.The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: Data from the National Registry of Myocardial Infarction 2[J].American Heart Journal.2001(6)
  • 6Robert J. Goldberg,Frederick A. Spencer,Joel M. Gore,Darleen Lessard,Jorge Yarzebski.Thirty-Year Trends (1975 to 2005) in the Magnitude of, Management of, and Hospital Death Rates Associated With Cardiogenic Shock in Patients With Acute Myocardial Infarction: A Population-Based Perspective[J]. Circulation . 2009 (9)
  • 7Levine GN, O'Gara PT, Bates ER, et al. 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: an update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions[J].J Am Coll Cardiol, 2015, pii: S0735 - 1097 ( 15 )06797 -2.
  • 8Toma M, Buller CE, Westerhout CM, et al. Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial[J]. Eur Heart J, 2010, 31 ( 14): 1701 - 1707.
  • 9Vlaar pJ, Mahmoud KD, Holmes DR Jr, et al. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis[J]. J Am Coll Cardiol, 2011, 58(7): 692-703.
  • 10Dziewierz A, Siudak Z, Rakowski T, et al. Impact of multivessel coronary artery disease and noninfarct-related artery revascularization on outcome of patients with ST-elevation myocardial infarctiontransferred for primary percutaneous coronary intervention (from the Eurotransfer Registry) [J]. AmJ Cardiol, 2010, 106(3): 342-347.

共引文献177

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部